111 related articles for article (PubMed ID: 15796183)
21. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
[TBL] [Abstract][Full Text] [Related]
22. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth.
Gavrilov V; Steiner M; Shany S
Anticancer Res; 2005; 25(5):3425-9. PubMed ID: 16101159
[TBL] [Abstract][Full Text] [Related]
23. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
24. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region.
Flahaut M; Mühlethaler-Mottet A; Martinet D; Fattet S; Bourloud KB; Auderset K; Meier R; Schmutz NB; Delattre O; Joseph JM; Gross N
Genes Chromosomes Cancer; 2006 May; 45(5):495-508. PubMed ID: 16450357
[TBL] [Abstract][Full Text] [Related]
25. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
Zheng X; Chang RL; Cui XX; Avila GE; Hebbar V; Garzotto M; Shih WJ; Lin Y; Lu SE; Rabson AB; Kong AN; Conney AH
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3444-51. PubMed ID: 16740769
[TBL] [Abstract][Full Text] [Related]
26. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
[TBL] [Abstract][Full Text] [Related]
27. Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCzeta activation.
Sánchez AM; Malagarie-Cazenave S; Olea N; Vara D; Cuevas C; Díaz-Laviada I
Eur J Pharmacol; 2008 Apr; 584(2-3):237-45. PubMed ID: 18343365
[TBL] [Abstract][Full Text] [Related]
28. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
29. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
31. Non-genomic effects of the androgen receptor and vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells.
Bonaccorsi L; Marchiani S; Ferruzzi P; Muratori M; Crescioli C; Forti G; Maggi M; Baldi E
Steroids; 2006 Apr; 71(4):304-9. PubMed ID: 16289173
[TBL] [Abstract][Full Text] [Related]
32. Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth.
Peternac D; Klima I; Cecchini MG; Studer UE; Thalmann GN
J Urol; 2006 Jul; 176(1):354-60. PubMed ID: 16753443
[TBL] [Abstract][Full Text] [Related]
33. Substituted steroidal compounds containing amino and amido groups reverse multidrug resistance of mouse T-lymphoma and two human prostate cancer cell lines in vitro.
Csonka Á; Hamdoun S; Spengler G; Martins A; Vincze I; Efferth T; Molnár J
Anticancer Res; 2015 Apr; 35(4):2105-12. PubMed ID: 25862866
[TBL] [Abstract][Full Text] [Related]
34. Effect of capsaicin on prostate cancer cells.
Díaz-Laviada I
Future Oncol; 2010 Oct; 6(10):1545-50. PubMed ID: 21062154
[TBL] [Abstract][Full Text] [Related]
35. Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol.
Karaca B; Kucukzeybek Y; Gorumlu G; Erten C; Gul MK; Cengiz E; Atmaca H; Uzunoglu S; Sanli UA; Karabulut B; Uslu R
Eur Cytokine Netw; 2008 Dec; 19(4):176-84. PubMed ID: 19103523
[TBL] [Abstract][Full Text] [Related]
36. Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy.
Pinto AC; Ângelo S; Moreira JN; Simões S
Cancer Chemother Pharmacol; 2011 Feb; 67(2):275-84. PubMed ID: 20379816
[TBL] [Abstract][Full Text] [Related]
37. Zinc functions as a cytotoxic agent for prostate cancer cells independent of culture and growth conditions.
Kriedt CL; Baldassare J; Shah M; Klein C
J Exp Ther Oncol; 2010; 8(4):287-95. PubMed ID: 21222361
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of novel cytotoxic phospholipids for prostate cancer.
Gududuru V; Hurh E; Durgam GG; Hong SS; Sardar VM; Xu H; Dalton JT; Miller DD
Bioorg Med Chem Lett; 2004 Oct; 14(19):4919-23. PubMed ID: 15341952
[TBL] [Abstract][Full Text] [Related]
39. [The role of alphavbeta3 integrin in changes of the invasive phenotype in CP-transformed fibroblasts with multiple drug resistance].
Morozevich GE; Kozlova NI; Chubukina AN; Berman AE
Vopr Med Khim; 2002; 48(1):111-20. PubMed ID: 12068493
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of the effect of multidrug resistance modifiers on prostate cancer, mouse lymphoma and colon cancer cells].
Csonka Á
Orv Hetil; 2016 Sep; 157(37):1489-95. PubMed ID: 27615200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
